United Financial Planning Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Buy
+409
New +$17.6K 0.01% 169
2026
Q1
Sell
-538
Closed -$27.4K 566
2025
Q4
$27.4K Buy
538
+129
+32% +$6.6K 0.02% 117
2025
Q3
$22.7K Buy
+409
New +$23.9K 0.01% 117

Other funds holding NVO

United Financial Planning Group's NVO Position: Q2 2026 in Review

United Financial Planning Group opened a new position in Novo Nordisk (NVO) in Q2 2026: 409 shares worth $19.6K. The stake represents 0.01% of the portfolio and ranks #169 among its holdings. This is a return to the name: United Financial Planning Group previously reported a position in NVO as recently as Q4 2025.

United Financial Planning Group first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $27.4K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • United Financial Planning Group held 409 shares of Novo Nordisk worth $19.6K as of Q2 2026.
  • Novo Nordisk was a new United Financial Planning Group position in Q2 2026.
  • Novo Nordisk made up 0.01% of United Financial Planning Group's portfolio in Q2 2026, its #169 holding.
  • United Financial Planning Group first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • United Financial Planning Group's Novo Nordisk position peaked at $27.4K in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on United Financial Planning Group's 13F filing for Q2 2026, filed 6 Aug 2026.